One thing pharma companies are not cutting back on right now is compliance and quality.
A recent survey by compliance specialist Sparta revealed that 80% of quality managers stated their budget had been excluded from cut backs. At a time when the power of brands is vital in retaining customer loyalty it seems companies are doing all they can to avoid any negative associations through non compliance or quality issues.
It was also interesting to note that 81 percent of respondents said that compliance with regulations is still the main driver of quality management initiatives. Here at PRISYMID we have actually seen an increase over the last 6 months in labeling projects relating to compliance which seems to bear out the findings of this survey.
Read more about the survey here
